Well another short and simple one, with no appendix this time. The overall market for the week was a general pull back, the NASDAQ composite dropping another -2% (though still +30% for the year. As for the Biotech indices, once again the NASDAQ biotech composite was up a point for the week, while the S&P biotch continued to slide, -1.4% for the week. So now, the S&P biotech YTD performance -3.8%) has dropped below the NASDAQ biotech, -2.3%.
This week’s top performing individual stock was ETON, up 32%, mostly on Friday after the release of its 2nd quarter financials, where earnings and revenue “beat expectations,” which might be an understatement given that the consensus earnings per share was a loss of -$0.09, but the reported earnings was a profit of +$0.18. The same day second place Eli Lily (LLY), a Big Pharma, came out with their second quarter results, with a strong growth in year over year profits, predominantly for the success of one of its diabetes treatments. Note that Mounjaro, their “diabetes” drug is also being used as a weight loss drug,
None of this week’s top five winners were among the YTD top performers. URGN was in the black, +16%, to overtake PRVB and move into fourth place YTD.
On the losing side of the ledger, QSI shed -64% of its initial share price in the past week, most of which was right at the opening bell, 9:30 am EDT Monday when 325 million shares were traded, a mere ninety minutes after the release of *their* financials. Likewise, the second worst performer for the week was JSPR, off -29%, although in this case the big downward jump commenced the day *before* the release of their earnings and revenue. Hmmmm. JSPR is still in second place for YTD performance, but its loss was a big contributor to Bladerunner’s drop of -$4k in value for the week.
It’s yet another week where the contest portfolios didn’t particularly shine, with the average portfolio dropping -$3.2k for the week. This resulted in the average YTD return moving into the red for the first time, -$1.7k, The median YTD portfolio is even worse, -$10k. Only three contestants made a profit this week. The best was ERIKOTTO, +$3.8k, underwritten by 15% stakes in CABA and URGN earning them +$2.5k each, with strong, but not top five quality, returns this week. ERIKOTTO traded places with STEVE LOKNESS (weighed down by having positions in QSI and MRUS), the third and fifth best performing portfolios YTD. JSPR’s bad week was the biggest reason that now the separation between ALONER and BLADERUNNER in the YTD standings has now widened to $7.4k.
Report Time Ranges
|
|
|
|
|
| From
| To
|
|
|
|
|
|
|
|
| Recent
| 8/4/23
| 8/11/23
|
|
|
|
|
|
|
|
| YTD
| 12/31/2022
|
|
|
|
| Index Portfolios’ Performance
|
|
|
|
| Symbol
| Recent P/L
| Recent %
| YTD P/L
|
|
|
|
|
|
|
|
| ^IXIC
| -$2,526.04
| -1.9%
| $30,367.12
|
|
|
|
|
|
|
|
| ^NBI
| $1,069.94
| 1.1%
| -$2,313.96
|
|
|
|
|
|
|
|
| ^SPSIBI
| -$1,367.74
| -1.4%
| -$3,824.96
|
|
|
|
| Share Performance
| Recent Performance
| YTD Performance
|
| Top Five
|
| Bottom Five
|
| Top Five
|
| Bottom 5
| Symbol
| P/L / Initial Price
| Symbol
| P/L / Initial Price
| Symbol
| YTD P/L / Initial Price
| Symbol
| YTD P/L/ Initial Price
| ETON
| 31.6%
| QSI
| -64.5%
| INZY
| 369.5%
| AVTX
| -97.5%
| LLY
| 21.5%
| JSPR
| -29.0%
| JSPR
| 187.8%
| APTA.L
| -96.0%
| VKTX
| 21.3%
| HROW
| -26.4%
| CRVS
| 163.5%
| PTEIQ
| -89.6%
| MRTX
| 20.6%
| DCTH
| -24.2%
| URGN
| 149.8%
| ALT
| -81.7%
| CRDF
| 19.3%
| MRUS
| -21.8%
| PRVB
| 136.5%
| MRSN
| -78.7%
| Average and Median Portfolio Performance
|
| Recent P/L
|
|
|
| YTD P/L
|
|
|
| Avg.
| Median
|
|
|
| Avg
| Median
|
|
|
| -$3,192.44
| -$3,462.58
| JACK HARTMANN
|
| -$1,691.42
| -$9,950.82
| TOMATO
| Top Seven Portfolio Performances
| Top Recent Performers
| Top YTD Performers
| Contestant (Prev. Rank)
| Recent P/L
| P/L vs. ^SPSIBI
| YTD P/L (Rank)
| Contestant (Prev. Rank)
| YTD P/L
| vs. Top Portfolio
| P/L vs. ^SPSIBI
| Rec. P/L (Rank)
| 1 - ERIKOTTO (12)
| $3,840.90
| $5,208.64
| $32,564.02 (3)
| 1 - ALONER (1)
| $45,405.85
| ——
| $49,230.81
| -$1,154.26 (4)
| 2 - RKRW (3)
| $794.75
| $2,162.49
| $30,791.50 (4)
| 2 - BLADERUNNER (2)
| $38,015.95
| $7,389.90
| $41,840.92
| -$3,987.42 (11)
| 3 - A.J. MULLEN (11)
| $475.66
| $1,843.40
| -$4,648.81 (7)
| 3 - ERIKOTTO (5)
| $32,564.02
| $12,841.83
| $36,388.98
| $3,840.90 (1)
| 4 - ALONER (8)
| -$1,154.26
| $213.48
| $45,405.85 (1)
| 4 - RKRW (4)
| $30,791.50
| $14,614.34
| $34,616.47
| $794.75 (2)
| 5 - BMAZ001 (5)
| -$2,953.98
| -$1,586.24
| -$49,878.87 (15)
| 5 - STEVE LOKNESS (3)
| $24,013.87
| $21,391.98
| $27,838.83
| -$11,331.16 (15)
| 6 - ARTHUR RADLEY (15)
| -$3,153.27
| -$1,785.53
| -$3,134.45 (6)
| 6 - ARTHUR RADLEY (6)
| -$3,134.45
| $48,540.30
| $690.51
| -$3,153.27 (6)
| 7 - RAJU_BIJLEE (14)
| -$3,438.31
| -$2,070.58
| -$30,040.91 (13)
| 7 - A.J. MULLEN (7)
| -$4,648.81
| $50,054.66
| -$823.85
| $475.66 (3)
| Top Portfolios’ Contents
| Top Recent Performance Portfolio (ERIKOTTO)
| Top YTD Performance Portfolio (ALONER)
| Symbol (Rank)
| Current Allocation
| Value/Total | ROI
| YTD Stock P/L
| Recent Stock P/L
| % Current Price Change for $1,000 P/L
| Symbol (Rank)
| Initial Allocation
| Value/Total | ROI
| YTD Stock P/L
| Recent Stock P/L
| % Current Price Change for $1,000 P/L
| CABA
| 15.0%
| 16.7% | 47.2%
| $7,086.49
| $2,545.95
| 4.5%
| AFMD
| 10%
| 4.2% | -52.0%
| -$6,564.54
| -$527.26
| 16.5%
| DAWN
| 10.0%
| 4.7% | -37.5%
| -$3,750.00
| $255.58
| 16.0%
| CDTX
| 10%
| 10.6% | 22.2%
| $2,806.21
| $59.85
| 6.5%
| FULC
| 10.0%
| 4.5% | -40.4%
| -$4,038.46
| $535.71
| 16.8%
| CLSD
| 10%
| 8.3% | -4.3%
| -$547.71
| -$575.25
| 8.3%
| ICVX
| 5.0%
| 3.7% | -2.1%
| -$107.05
| -$623.43
| 20.4%
| CRDF
| 10%
| 12.1% | 39.3%
| $4,960.84
| $2,398.48
| 5.7%
| INZY
| 5.0%
| 17.7% | 369.5%
| $18,476.19
| -$428.57
| 4.3%
| CRIS
| 10%
| 10.0% | 14.8%
| $1,868.66
| -$623.74
| 6.9%
| LIFE
| 10.0%
| 6.9% | -8.7%
| -$867.58
| $0.00
| 11.0%
| CRVS
| 10%
| 21.7% | 149.6%
| $18,888.71
| $844.20
| 3.2%
| OCUL
| 10.0%
| 11.7% | 54.8%
| $5,480.43
| -$569.40
| 6.5%
| KZIA
| 10%
| 12.0% | 38.3%
| $4,839.36
| -$2,365.37
| 5.7%
| PDSB
| 10.0%
| 2.8% | -63.3%
| -$6,325.76
| -$431.82
| 27.2%
| MGTA
| 10%
| 15.9% | 82.6%
| $10,429.65
| $143.22
| 4.3%
| PRQR
| 10.0%
| 3.1% | -58.6%
| -$5,864.86
| $54.05
| 24.2%
| MRNA
| 10%
| 5.3% | -39.0%
| -$4,927.18
| -$508.38
| 13.0%
| URGN
| 15.0%
| 28.3% | 149.8%
| $22,474.63
| $2,502.82
| 2.7%
| PRVB
| 10%
| 0.0% | 136.5%
| $13,651.84
| $0.00
| --
|
|
